News
Government sidesteps committee call on CGMs, insulin pumps and GLP1 access
18+ hour, 53+ min ago (131+ words) Pharma Dispatch Government sidesteps committee call on CGMs, insulin pumps and GLP1 access In its report, the Committee urged clear, practical expansions of access to continuous glucose monitors (CGM), insulin pumps and GLP1 medicines. The Government acknowledges these concerns but stops far…...
Aus Biotech welcomes Budget's creation of new National Resilience and Science Council
3+ day, 17+ hour ago (154+ words) Aus Biotech welcomes Budget moves but cautions on unintended consequences Pharma Dispatch Aus Biotech welcomes Budget's creation of new National Resilience and Science Council Aus Biotech says the 2026-27 Federal Budget sends strong signals that the Government has listened to its…...
Long-term study finds continuing Mounjaro helps maintain weight loss - Bio Pharma Dispatch
4+ day, 17+ hour ago (143+ words) Long-term study finds continuing Mounjaro helps maintain weight loss Pharma Dispatch Long-term study finds continuing Mounjaro helps maintain weight loss Gareth Richmond, Business Unit Leader for Cardiometabolic Health at Eli Lilly Australia and New Zealand, said the study answers an…...
Budget pledges $71 million to expand precision oncology for Australians with advanced cancer - Bio Pharma Dispatch
5+ day, 14+ hour ago (280+ words) The new investment will fund free comprehensive genomic profiling of tumour DNA for Australians with advanced or incurable cancers and support matching to advanced treatments and clinical trials. Budget pledges $71 million to expand precision oncology for Australians with advanced cancer…...
Disappointment for diabetes advocates in response to Government budget silence
5+ day, 16+ hour ago (138+ words) Pharma Dispatch Disappointment for diabetes advocates in response to Government budget silence Advocates for people living with diabetes expressed disappointment after the 202627 Federal Budget made no new commitments to improving care for the condition that affects millions of Australians. " Budget…...
Stakeholders must act to protect their voice in response to the risk of a manufactured consensus
1+ week, 3+ day ago (140+ words) Pharma Dispatch Stakeholders must act to protect their voice in response to the risk of a manufactured consensus Officials will use participation as evidence that the process was inclusive and broadly supported. That claim provides procedural cover for inaction, allowing…...
If the imperative is international comparison, why limit it to these definitions?
1+ week, 5+ day ago (133+ words) Pharma Dispatch If the imperative is international comparison, why limit it to these definitions? International comparisons might matter, but only if we employ them consistently. Why limit international comparisons, and why are officials redoing so much of what was already…...
Medicines Australia calls for transparency, highlighting the risk of bias
1+ week, 6+ day ago (146+ words) Pharma Dispatch Medicines Australia calls for transparency, highlighting the risk of bias "We are seeking greater transparency of the protocol itself and the stakeholders that have been invited to participate, as there are inherent biases in an anonymous Delphi protocol…...
Australia approves first in class therapy for chronic graft versus host disease
1+ week, 6+ day ago (135+ words) Pharma Dispatch Australia approves first in class therapy for chronic graft versus host disease Specialised Therapeutics secured the rights to NIKTIMVO in Australia, New Zealand, and Singapore via a June 2025 agreement with Incyte. The company said it is exploring reimbursement…...
Lilly therapy approved in Australia as first non-covalent BTK inhibitor for common blood cancer
1+ week, 6+ day ago (157+ words) Pharma Dispatch Lilly therapy approved in Australia as first non-covalent BTK inhibitor for common blood cancer "We acknowledge there are significant challenges involved in securing reimbursement for innovative medicines in Australia, and our focus in the near term is on…...